Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase 2 study of rucaparib and nivolumab in small cell lung cancer is displayed, including study design, eligibility criteria, outcomes, and a Kentucky study location. The record also includes results and study documents.
    Difference
    51%
    Check dated 2026-11-09T12:48:06.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T12:21:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T11:57:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:36:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:12:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is temporarily inaccessible due to permission restrictions.
    Difference
    19%
    Check dated 2026-09-21T21:52:37.000Z thumbnail image

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.